Monday, October 27, 2014
IMIG: Dr. Constantine Alifrangis Speaks on Next Generation Sequencing in Mesothelioma
genomes and how it might be used to identify new treatments and individualize care for patients with mesothelioma. These approaches have identified specific genomic alterations in mesothelioma associated with unexpected drug sensitivities in mesothelioma. As for other cancers, study of cancer genomes in mesothelioma has the potential to guide development of novel therapies for this disease.Click here to hear and see more about this work.